focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So its about TA after all is it Bella?
Timing is everything, but unfortunately coming form a low life scumbag, its probably not somebody you want to engage in a conversation with.....
Great news hopefully 48p soon.
43 continues to be the bottom/resistance. Looks like someone is calling the shorts here and the likes of GSP isn't breaking the barrier....mmm
What are you even talking about, you assume Avacta will sell the company cheap based on how fast the platform can be developed by a third party for the future benefit of man kind!! heard it all now, as I said we are a business not a charity fair value will be paid by someone, because let’s be honest here if the data remains exceptional whoever owns this technology will have a monopoly on targeted precision chemo warheads moving forward. Competition will kick in with multiple pharmaceutical companies bidding once the ball gets rolling. Why do you think these pharmaceutical companies Mkt caps are so high, it’s certainly not because they are selling drugs cheap for future mankind and identity themselves as charities, they are money making corporate machines.
Indeed, of all the paid trolls, touk always came across as the simple one, making up incoherent nonsense, wasting everyone's time....
Touk you worry me.
Why would a BP carry on with ADC’s that give off horrendous side effects and only a small number have made it to market, but have the holy grail worth many more billions than they have invested in toxic ADC’s and just lock it away.
You are a paid troll and not a very good one.🤡
You are fantasising out loud now, and coming across a bit incoherent. What the actual does this mean?
"Our IIs have a longer term view than us and probably a far smaller proportion of their investment funds invested."
Longer term view? If they voted for a £1 takeover that is just a short term shafting. What has the size of their investment got to do with it?
Are you drunk or high?
Our IIs have a longer term view than us and probably a far smaller proportion of their investment funds invested.
How about this for a scenario::
A big bad BP with billions invested in ADC buys us for £2 a share and then locks the IP away in a safe for 5 years?
The II's and the PI's hold equivalent shares. Under your proposal II's get shafted too.
Ice
It won’t matter what PIs want.
Certainly I think the BoD and the IIs will want a quick path to commercialisation of the pipeline. We are talking peanuts for what AVA6000 will be worth in comparison. An assured future and £billions is far more important than peanuts today.
So Touk a preclinical phase Company for a promising drug got an offer for 1.75bn yet you say Avacta going to get taken over for approx 300m when we have spent over a year in the clinic with exceptional results and biopsy data. What a load of BS and based on no factual evidence whatsoever of what happens in this industry. Sorry but I couldn’t care less if a future partner develops this technology, we are not a charity the shareholders will want fair compensation and value.
In that scenario, deal is roundly rejected and the share price resets to £1 and continues to rise on the basis we've had an offer.
You still don’t get it do you?
This isn’t a bank or a miner or manufacturer or a retailer
The money is far less important that what the new parent can offer regarding the future for the technology and associated pipeline of drugs and the careers of the BoD and key employees.
It is already a done deal 50p+ 50p worth of shares in Novartis. IMHO of course
More M&A in biotechs.
Avacta will be in demand at ASCO.
"Johnson & Johnson agreed to buy biotechnology startup Proteologix for $850 million in cash, gaining a portfolio of bispecific antibodies the privately held company has been developing for immune diseases."
i'll give you £1.50 to **** off. send me your bank details.
I would take 10p tbh, wow ThE WaIT iS So FrUSTRatinG….
I'd take £1.50 to be out of this S**T show
We can kill cancer! There will be many offers on the table
I think you are kidding yourselves. . No bidding war because there are no multiple interested parties, or even a single interested party. Where was the institutional interest when we were fund raising at a 50% discount? Holders always think offers will come in at their target value and it never happens. Look at whats happened with SOLG. Someone approaching this new today would not pay £2/£3. First offer would be 65p, second 80p, would probably get it. All those new shareholders at 50p would certainly accept 80p.
Yes, they've added the Managing Director of Launch Diagnostics Deutschland GmbH. Worth an RNS to announce the launch of this new subsidiary and appointment of its MD? Nah, keep it all quiet.
£3 would never go through
It will go to a bidding war
Why would any big pharma not want us
It's worth what somebody will pay - same as anything - £3 will do me fine.
Rambo please don't encourage him !!!
T/O Worth some where between £7-£10
I think of this share rather like a new discovery of a painting that could be by.. Renoir, Michelangelo, Van Gogh, OR it could be a pastiche and only in the *style* of said artist.
The authenticated value will be multiple times the value of a painting by a nobody.
43.75 is the Un-authenticated value while the experts study the brush work.
Would be nice if they could crack on with the authentication.